AI assistant
Ambu Major Shareholding Notification 2022
3353_rns_2022-06-01_f01d3cb4-36bb-45b9-b90c-43cc2f5a9251.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Ambu
COMPANY ANNOUNCEMENT
Major shareholder announcement - Bank of America
Ambu A/S hereby announces in reference to Section 30 of the Danish Capital Markets Act that on April 26, 2022, pursuant to Section 38(1) of the Danish Capital Markets Act, Ambu has received a major shareholder notification from Bank of America Corporation bringing Bank of America Corporation above 5% of share capital or voting rights in Ambu A/S.
See attached standard form for notification of major holdings from Danish FSA.
Contacts
Investors
Michael Højgaard, CFO, [email protected] / +45 4030 4349
Nicolai Thomsen, Director, Investor Relations & Strategic Financial Planning, [email protected] / +45 2620 8047
Ambu A/S
Baltorpbakken 13, DK-2750 Ballerup, Denmark, Tel.: +45 7225 2000, CVR no.: 63 64 49 19, www.ambu.com
About Ambu
Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring solutions. We continuously look to the future with a commitment to deliver innovative quality products that have a positive impact on patient care and the work of healthcare professionals. Headquartered near Copenhagen in Denmark, Ambu employs approximately 4,500 people in Europe, North America and the Asia Pacific. For more information, please visit ambu.com or ambuUSA.com or follow us on our corporate LinkedIn and USA LinkedIn pages.
Ambu
Company announcement no. 9 2021/22
27 April 2022